BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29538593)

  • 21. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-operative optical coherence tomography in corneal lamellar graft reinforcement for Boston type I keratoprosthesis corneal melt.
    Zeng L; Chen M; Lin L; Zhai J; Chen J; Gu J
    Indian J Ophthalmol; 2023 Jul; 71(7):2892-2896. PubMed ID: 37417141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periprosthetic Tissue Loss in Patients With Idiopathic Vitreous Inflammation After the Boston Keratoprosthesis.
    Grassi CM; Cruzat A; Taniguchi EV; Crnej A; Colby KA; Dohlman CH; Chodosh J
    Cornea; 2015 Nov; 34(11):1378-82. PubMed ID: 26226472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical applications of anterior segment optical coherence tomography imaging following corneal surgery.
    Sayegh RR; Pineda R
    Semin Ophthalmol; 2012; 27(5-6):125-32. PubMed ID: 23163266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography.
    Fernandez AG; Radcliffe NM; Sippel KC; Rosenblatt MI; Sood P; Starr CE; Ciralsky JB; D'Amico DJ; Kiss S
    Clin Ophthalmol; 2012; 6():1355-9. PubMed ID: 22969280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional anterior segment imaging in patients with type 1 Boston Keratoprosthesis with switchable full depth range swept source optical coherence tomography.
    Poddar R; Cortés DE; Werner JS; Mannis MJ; Zawadzki RJ
    J Biomed Opt; 2013 Aug; 18(8):86002. PubMed ID: 23912759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year results and anterior segment optical coherence tomography findings of descemet stripping automated endothelial keratoplasty combined with phacoemulsification.
    Yoo SH; Kymionis GD; Deobhakta AA; Ide T; Manns F; Culbertson WW; O'Brien TP; Alfonso EC
    Arch Ophthalmol; 2008 Aug; 126(8):1052-5. PubMed ID: 18695098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal imaging with anterior segment optical coherence tomography for lamellar keratoplasty procedures.
    Lim LS; Aung HT; Aung T; Tan DT
    Am J Ophthalmol; 2008 Jan; 145(1):81-90. PubMed ID: 18028862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal deturgescence after Descemet stripping automated endothelial keratoplasty evaluated by Visante anterior segment optical coherence tomography.
    Di Pascuale MA; Prasher P; Schlecte C; Arey M; Bowman RW; Cavanagh HD; McCulley JP; Mootha VV
    Am J Ophthalmol; 2009 Jul; 148(1):32-7.e1. PubMed ID: 19327750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
    Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
    Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AlphaCor keratoprosthesis: postoperative development of six patients.
    Holak SA; Holak HM; Bleckmann H
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):535-9. PubMed ID: 18941767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra high resolution optical coherence tomography in Boston type I keratoprosthesis.
    Zarei-Ghanavati S; Betancurt C; Mas AM; Wang J; Perez VL
    J Ophthalmic Vis Res; 2015; 10(1):26-32. PubMed ID: 26005549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes After Auro Keratoprosthesis Implantation: A Low-Cost Design Based on the Boston Keratoprosthesis.
    Venugopal A; Rathi H; Rengappa R; Ravindran M; Raman R
    Cornea; 2016 Oct; 35(10):1285-8. PubMed ID: 27429086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.